Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EPA/IPH stock hub

EPA/IPH has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

EPA/IPHis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
117.7M
Euronext Paris
Market data

Price

Recent price action with selectable time range.

EPA/IPHEPA/IPH
—
Loading chart…
In the news

Latest news · EPA/IPH

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E1.3
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC-165.9
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All EPA/IPH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
171
Groups with data
11
Currency
EUR
Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
France
Country code
FR
Employees
174
Employees Change
-7%
Employees Change Percent
-3.87
Enterprise value
EUR 105.9M
Exchange
Euronext Paris
Financial currency
EUR
First seen
2026-05-10
Industry
Biotechnology
Isin
FR0010331421
Last refreshed
2026-05-10
Market cap
EUR 117.7M
Price
EUR 1.25
Price currency
EUR
Rev Per Employee
55,245.4x
Sector
Healthcare
Sic
2836
Symbol
epa/IPH
Website
https://www.innate-pharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

8
MetricValue
Earnings Yield
-41.8%
EV Earnings
-2.15x
EV/FCF
-2x
EV/Sales
11.76x
FCF yield
-44.96%
Forward P/E
1.32x
P/B ratio
-5.42x
P/S ratio
13.07x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

9
MetricValue
Gross Profit
EUR -34.6M
Net Income
EUR -49.2M
Net Income Growth Years
1%
Pretax Margin
-546.11%
Profit Per Employee
EUR -301,699
ROA
-38.85
Roa5y
-16.08
ROCE
-207.2
ROIC
-165.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr10y
-20.09%
Cagr15y
-0.96%
Cagr1y
-37.94%
Cagr3y
-22.84%
Cagr5y
-17.58%
EPS Growth Years
1
Revenue Growth
-55.25x
Revenue Growth Q
-46.7x
Revenue Growth Years
0x
Revenue Growth3 Y
-35.65x
Revenue Growth5 Y
-29.66x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Asset Turnover
EUR 0.1
Assets
EUR 62.7M
Cash
EUR 34.3M
Current Assets
EUR 46.7M
Current Liabilities
EUR 36.6M
Debt
EUR 22.6M
Debt FCF
EUR -0.43
Equity
EUR -21.7M
Interest Coverage
-122.7
Liabilities
EUR 84.4M
Long Term Assets
EUR 16M
Long Term Liabilities
EUR 47.8M
Net Cash
EUR 11.7M
Net Cash By Market Cap
EUR 9.98
Net Cash Growth
-76.42%
Tangible Book Value
EUR -21.7M
Tangible Book Value Per Share
EUR -0.23
WACC
7.53

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
1.27
Net Working Capital
EUR -15.4M
Quick ratio
1.14
Working Capital
EUR 10.1M
Working Capital Turnover
EUR 0.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-10.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-89.37%
1Y total return
-37.92%
200-day SMA
1.57
3Y total return
-54.07%
50-day SMA
1.25
50-day SMA vs 200-day SMA
50under200
5Y total return
-61.95%
All Time High
17.85
All Time High Change
-92.97%
All Time High Date
2015-04-27
All Time Low
1.03
All Time Low Change
21.75%
All Time Low Date
2026-03-23
ATR
0.07
Beta
0.81
Beta1y
1.68
Beta2y
1.13
Ch YTD
-21.72
High
1.27
High52
2.08
High52 Date
2025-05-09
High52ch
-39.71%
Low
1.23
Low52
1.03
Low52 Date
2026-03-23
Low52ch
21.75%
Ma50ch
0.72%
Price vs 200-day SMA
-20.13%
RSI
52.63
RSI Monthly
38.78
RSI Weekly
43.48
Sharpe ratio
-0.73x
Sortino ratio
-1.02
Total Return
-10.54%
Tr YTD
-21.72
Tr15y
-13.52%
Tr1m
13.59%
Tr1w
0.64%
Tr3m
-12.31%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR -54M
Operating margin
-599.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
65,937,359%
Net Borrowing
-8,911,000
Shares Insiders
0.74%
Shares Institutions
1.61%
Shares Out
93,829,188
Shares Qo Q
6.11%
Shares Yo Y
10.54%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

51
MetricValue
Adjusted FCF
EUR -55.5M
Average Volume
411,730.35x
Bv Per Share
-0.23
CAPEX
EUR -140,000
Ch10y
-89.37
Ch15y
-13.52
Ch1m
13.59
Ch1w
0.64
Ch1y
-37.92
Ch3m
-12.31
Ch3y
-54.07
Ch5y
-61.95
Ch6m
-17.72
Change
-0.32%
Change From Open
0.48
Close
1.26
Days Gap
-0.79
Depreciation Amortization
700,000
Dollar Volume
141,552.8
Earnings Date
2026-09-17
EBIT
EUR -54M
EBITDA
EUR -53.3M
EPS
EUR -0.55
F Score
2
FCF
EUR -52.9M
FCF EV Yield
-49.94x
FCF Per Share
EUR -0.56
Financing CF
6,070,000
Fiscal Year End
December
Founded
1,999
Investing CF
7,289,000
Is Primary Listing
1
Last Earnings Date
2026-03-26
Last Report Date
2025-12-31
Ma150
1.49
Ma150ch
-15.73%
Ma20
1.24
Ma20ch
0.97%
Net CF
-38,304,000
Next Earnings Date
2026-09-17
Open
1.25
Position In Range
63.16
Ppne
4,356,000
Price Date
2026-05-08
Relative Volume
0.28x
Revenue
9,005,000x
SBC By Revenue
28.51x
Share Based Comp
2,567,000
Tr6m
-17.72%
Volume
112,881
Z Score
-11.09
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does EPA/IPH pay a dividend?

Capital-return profile for this ticker.

Performance

EPA/IPH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-37.9%
S&P 500 1Y: n/a
3Y total return
-54.1%
S&P 500 3Y: n/a
5Y total return
-62.0%
S&P 500 5Y: n/a
10Y total return
-89.4%
S&P 500 10Y: n/a
Ownership

Who owns EPA/IPH?

Insider, institutional, and short-interest positioning.

Institutional ownership
+1.6%
Share of float held by funds and institutions
Insider ownership
+0.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+10.5%
Negative means the company is buying back shares.
Technical

EPA/IPH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
52.6
Neutral momentum band
Price vs 200-day MA
-20.1%
50/200-day relationship not available
Beta (5Y)
0.81
Moves roughly with the market
Sharpe ratio
-0.73
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About EPA/IPH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current epa/IPH stock rating?

epa/IPH is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full epa/IPH analysis?

The full report lives at /stocks/epa/IPH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for epa/IPH?

The latest report frames epa/IPH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the epa/IPH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.